Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers

Introduction: Linezolid is a last-resort antibiotic for infections caused by multidrug-resistant microorganisms. It is widely used for off-label indications and for longer than recommended treatment durations, exposing patients at higher risk of adverse drug reactions (ADRs), notably thrombocytopeni...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Hélène Thirot, David Fage, Antonia Leonhardt, Philippe Clevenbergh, Tatiana Besse-Hammer, Jean Cyr Yombi, Olivier Cornu, Caroline Briquet, Maya Hites, Frédérique Jacobs, Gert-Jan Wijnant, Sebastian G. Wicha, Frédéric Cotton, Paul M. Tulkens, Anne Spinewine, Françoise Van Bambeke
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2024-01-01
Seri Bilgileri:	Frontiers in Pharmacology
Konular:	linezolid thrombocytopenia adverse drug reaction therapeutic drug monitoring anemia Buzelé score
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1310309/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers

Benzer Materyaller